Post Profile

Use Of Genetic Information May Help Predict Likelihood Of Survival Following Chemotherapy For Breast Cancer

Development of a predictive test that included genomic signatures that indicated chemoresistance, chemosensitivity and endocrine sensitivity for women with newly diagnosed breast cancer identified patients with a high probability of survival following chemotherapy, according to a study in the May 11 issue of JAMA. Identification of patients with high likelihood of survival following a standard chemotherapy regimen (and then endocrine therapy, if estrogen receptor [ER]-positive) would reaffirm a treatment decision regarding the use of chemotherapy.
read more


Related Posts

Genes In Healthy Breast Tissue May Predict Who Will Benefit From Drugs To Prevent Estrogen-Sensitive Breast Cancer

Health : Medical News Today

A newly identified set of genes may predict which women are at high risk for getting breast cancer that is sensitive to estrogen and, therefore, would be helped by taking drugs to prevent it, reports a new Northwestern Medicine stud...

Genetic testing can help predict if chemo will work

Health : The Chart

Researchers say a new genetic test for breast cancer patients may indicate whether standard chemotherapy treatments will work. Their study, published in the Journal of the American Medical Association, suggests the key to treating b...

New test shows promise for very early breast cancer patients

Health : The Checkup

A new genetic test appears to be effective for identifying women diagnosed with the earliest form of breast cancer who are least likely to suffer a recurrence, researchers reported Tuesday. The findings indicate the test could help ...

Some Breast Cancer Patients Spared Chemotherapy By New Genomic Test

Health : Medical News Today

Testing a breast cancer tumour for its genomic signature can help identify which patients will need adjuvant systemic therapy (additional chemotherapy) after surgery, and spare its use in those for whom it is not necessary, accordin...

Genomic Test Shows Promise As Predictor Of Chemotherapy Response, Survival For Women With Invasive Breast Cancer

Health : Medical News Today

A new genomic test combining multiple signatures a patient's estrogen receptor status, endocrine therapy response, chemotherapy resistance and sensitivity shows promise as a predictor of chemotherapy response and survival benefit in...


Copyright © 2016 Regator, LLC